$339.68
+0.13
(+0.04%)▲
Insights on Molina Healthcare, Inc.
Revenue is up for the last 5 quarters, 8.14B → 9.93B (in $), with an average increase of 4.8% per quarter
Netprofit is up for the last 2 quarters, 216.0M → 301.0M (in $), with an average increase of 28.2% per quarter
In the last 1 year, The Cigna Corp has given 40.1% return, outperforming this stock by 23.5%
In the last 3 years, Elevance Health, Inc has given 31.6% return, outperforming this stock by 3.2%
1.0%
Downside
Day's Volatility :1.42%
Upside
0.43%
21.59%
Downside
52 Weeks Volatility :37.17%
Upside
19.87%
Period | Molina Healthcare, Inc. | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | -3.25% | -0.8% | 3.4% |
6 Months | -2.54% | 10.5% | 17.7% |
1 Year | 16.58% | 6.4% | 26.3% |
3 Years | 28.37% | 14.6% | 23.1% |
Market Capitalization | 21.5B |
Book Value | $72.67 |
Earnings Per Share (EPS) | 18.77 |
PE Ratio | 19.57 |
PEG Ratio | -0.62 |
Wall Street Target Price | 417.41 |
Profit Margin | 3.31% |
Operating Margin TTM | 4.25% |
Return On Assets TTM | 7.43% |
Return On Equity TTM | 30.39% |
Revenue TTM | 33.0B |
Revenue Per Share TTM | 571.98 |
Quarterly Revenue Growth YOY | 6.3% |
Gross Profit TTM | 3.9B |
EBITDA | 1.7B |
Diluted Eps TTM | 18.77 |
Quarterly Earnings Growth YOY | 2.84 |
EPS Estimate Current Year | 23.56 |
EPS Estimate Next Year | 26.95 |
EPS Estimate Current Quarter | 4.35 |
EPS Estimate Next Quarter | 6.41 |
What analysts predicted
Upside of 22.88%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 18.9B | ↓ 4.99% |
Net Income | 707.0M | ↓ 238.09% |
Net Profit Margin | 3.74% | ↑ 6.32% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 16.8B | ↓ 10.91% |
Net Income | 737.0M | ↑ 4.24% |
Net Profit Margin | 4.38% | ↑ 0.64% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 19.4B | ↑ 15.41% |
Net Income | 673.0M | ↓ 8.68% |
Net Profit Margin | 3.46% | ↓ 0.92% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 27.8B | ↑ 42.98% |
Net Income | 659.0M | ↓ 2.08% |
Net Profit Margin | 2.37% | ↓ 1.09% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 32.0B | ↑ 15.13% |
Net Income | 792.0M | ↑ 20.18% |
Net Profit Margin | 2.48% | ↑ 0.11% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 34.1B | ↑ 6.56% |
Net Income | 1.1B | ↑ 37.75% |
Net Profit Margin | 3.2% | ↑ 0.72% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 8.2B | ↑ 3.73% |
Net Income | 56.0M | ↓ 75.65% |
Net Profit Margin | 0.68% | ↓ 2.22% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 8.1B | ↓ 0.9% |
Net Income | 321.0M | ↑ 473.21% |
Net Profit Margin | 3.94% | ↑ 3.26% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 8.3B | ↑ 2.18% |
Net Income | 309.0M | ↓ 3.74% |
Net Profit Margin | 3.71% | ↓ 0.23% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 8.5B | ↑ 2.65% |
Net Income | 245.0M | ↓ 20.71% |
Net Profit Margin | 2.87% | ↓ 0.84% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 9.0B | ↑ 5.85% |
Net Income | 216.0M | ↓ 11.84% |
Net Profit Margin | 2.39% | ↓ 0.48% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 9.9B | ↑ 9.76% |
Net Income | 301.0M | ↑ 39.35% |
Net Profit Margin | 3.03% | ↑ 0.64% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 7.2B | ↓ 15.55% |
Total Liabilities | 5.5B | ↓ 22.81% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.8B | ↓ 5.13% |
Total Liabilities | 4.8B | ↓ 12.35% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 9.5B | ↑ 40.44% |
Total Liabilities | 7.4B | ↑ 54.05% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 12.2B | ↑ 28.08% |
Total Liabilities | 9.6B | ↑ 28.82% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 12.3B | ↑ 0.86% |
Total Liabilities | 9.4B | ↓ 2.39% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 14.9B | ↑ 20.94% |
Total Liabilities | 10.7B | ↑ 14.19% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 12.3B | ↓ 3.74% |
Total Liabilities | 9.4B | ↓ 4.12% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.4B | ↑ 8.58% |
Total Liabilities | 10.1B | ↑ 7.84% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.7B | ↑ 2.17% |
Total Liabilities | 10.0B | ↓ 0.43% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 14.9B | ↑ 8.85% |
Total Liabilities | 11.0B | ↑ 9.47% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 14.9B | ↑ 0.15% |
Total Liabilities | 10.7B | ↓ 2.86% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 15.5B | ↑ 4.17% |
Total Liabilities | 11.0B | ↑ 3.21% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -314.0M | ↓ 139.05% |
Investing Cash Flow | 1.1B | ↓ 206.52% |
Financing Cash Flow | -1.2B | ↓ 287.58% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 427.0M | ↓ 235.99% |
Investing Cash Flow | -293.0M | ↓ 125.63% |
Financing Cash Flow | -552.0M | ↓ 53.73% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.9B | ↑ 342.62% |
Investing Cash Flow | -400.0M | ↑ 36.52% |
Financing Cash Flow | 225.0M | ↓ 140.76% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.1B | ↑ 12.12% |
Investing Cash Flow | -1.7B | ↑ 313.25% |
Financing Cash Flow | -183.0M | ↓ 181.33% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 773.0M | ↓ 63.52% |
Investing Cash Flow | -790.0M | ↓ 52.21% |
Financing Cash Flow | -441.0M | ↑ 140.98% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -212.0M | ↓ 183.46% |
Investing Cash Flow | -790.0M | ↓ 15.78% |
Financing Cash Flow | -183.0M | ↓ 1930.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 916.0M | ↓ 532.08% |
Investing Cash Flow | -302.0M | ↓ 61.77% |
Financing Cash Flow | -65.0M | ↓ 64.48% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 487.0M | ↓ 46.83% |
Investing Cash Flow | -137.0M | ↓ 54.64% |
Financing Cash Flow | 10.0M | ↓ 115.38% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 949.0M | ↑ 94.87% |
Investing Cash Flow | -719.0M | ↑ 424.82% |
Financing Cash Flow | -6.0M | ↓ 160.0% |
Sell
Neutral
Buy
Molina Healthcare, Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Molina Healthcare, Inc. | -9.49% | -2.54% | 16.58% | 28.37% | 161.29% |
The Cigna Corp | -5.24% | 11.3% | 40.14% | 31.6% | 115.05% |
Centene Corp. | 3.83% | 4.13% | 11.29% | 15.88% | 33.49% |
Unitedhealth Group Incorporated | 8.14% | -7.69% | 1.06% | 19.72% | 104.76% |
Cvs Health Corporation | -24.36% | -21.36% | -18.74% | -31.09% | -1.24% |
Elevance Health, Inc | 5.69% | 15.94% | 15.39% | 34.54% | 96.11% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Molina Healthcare, Inc. | 19.57 | 19.57 | -0.62 | 23.56 | 0.3 | 0.07 | NA | 72.67 |
The Cigna Corp | 20.25 | 20.25 | 0.89 | 28.43 | 0.12 | 0.04 | 0.02 | 158.03 |
Centene Corp. | 14.95 | 14.95 | 0.68 | 6.77 | 0.11 | 0.04 | NA | 48.35 |
Unitedhealth Group Incorporated | 29.77 | 29.77 | 1.24 | 27.62 | 0.17 | 0.07 | 0.02 | 100.18 |
Cvs Health Corporation | 10.47 | 10.47 | 1.0 | 8.3 | 0.11 | 0.04 | 0.04 | 59.36 |
Elevance Health, Inc | 20.12 | 20.12 | 1.14 | 37.28 | 0.16 | 0.06 | 0.01 | 174.62 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Molina Healthcare, Inc. | Buy | $21.5B | 161.29% | 19.57 | 3.31% |
The Cigna Corp | Buy | $99.9B | 115.05% | 20.25 | 2.65% |
Centene Corp. | Buy | $39.6B | 33.49% | 14.95 | 1.91% |
Unitedhealth Group Incorporated | Buy | $448.4B | 104.76% | 29.77 | 4.05% |
Cvs Health Corporation | Buy | $85.4B | -1.24% | 10.47 | 2.34% |
Elevance Health, Inc | Buy | $124.0B | 96.11% | 20.12 | 3.64% |
Vanguard Group Inc
Capital World Investors
BlackRock Inc
T. Rowe Price Associates, Inc.
Wellington Management Company LLP
State Street Corporation
molina healthcare is a fortune 500 company that is focused exclusively on government-sponsored health care programs for families and individuals who qualify for government sponsored health care. molina healthcare contracts with state governments and serves as a health plan providing a wide range of quality health care services to families and individuals. molina healthcare offers health plans in california, florida, illinois, michigan, new mexico, ohio, south carolina, texas, utah, washington, wisconsin and puerto rico. molina also offers a medicare product and has been selected in several states to participate in duals demonstration projects to manage the care for those eligible for both medicaid and medicare. molina healthcare owns and operates primary care clinics in california, florida, new mexico, washington and virginia. our medical offices provide individuals who qualify for government sponsored programs with medical care including prenatal care, immunizations, and flu shots
Organization | Molina Healthcare, Inc. |
Employees | 18000 |
CEO | Mr. Joseph Michael Zubretsky |
Industry | Health Services |